Clinical Trial Update: BIS-001-ER for the Treatment of Adult Focal Impaired Awareness Seizures [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for BIS-001-ER in adults with focal impaired awareness seizures, currently active but not recruiting, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Impaired Awareness Seizures

Drugs mentioned

• BIS-001-ER

Snippet

Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Focal Impaired Awareness Seizures | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING